Objective: To investigate the pathological types and endoscopic features of SMT in upper gastrointestinal tract.Methods: Clinical data of 285 patients with SMT in upper gastrointestinal tract were retrospectively chosen in the period from June 2016 to December 2019. The general data, pathological location, pathological type, origin and endoscopic features were analyzed.Results: ① In total of 124 cases for esophageal SMT, 35 were located in the upper esophagus, accounting for 28.23%; 42 in the middle esophagus, accounting for 33.87%; 47 in the lower esophagus, accounting for 37.90%; leiomyoma was the most common. ② In total of 149 cases for gastric SMT, 14 cases were in the cardia, accounting for 9.39%, leiomyoma and stromal tumor were the most common; 51 cases were in the bottom of the stomach, accounting for 34.23%, stromal tumor and leiomyoma were the most common; 45 cases were in the upper part of the stomach, accounting for 30.20%, leiomyoma and stromal tumor were the most common; 7 cases were in the middle of the stomach, accounting for 4.70%, stromal tumor and leiomyoma were the most common. There were 5 cases in the lower part of the stomach, accounting for 3.36% of the total, with leiomyoma and ectopic pancreas the most common; 1 cases in the angle of the stomach, accounting for 0.67% of the total; 26 cases in the antrum, accounting for 17.45%, with ectopic pancreas and stromal tumor the most common. ③ In total of 12 cases for duodenal SMT, 10 cases were in the duodenal bulb, accounting for 83.33%, cyst were the most common; 2 cases were in the duodenal descending part, accounting for 16.67%, lipoma were the most common. ④ The total coincidence rate of endoscopic type diagnosis and postoperative pathological diagnosis of esophageal SMT was 92.74% (115/124), including leiomyoma for 98.06% (101/103) and cyst for 72.73% (8/11). ⑤ The total coincidence rate of endoscopic type diagnosis and postoperative pathological diagnosis of gastric SMT was 93.29% (139/149), including stromal tumor and leiomyoma for 100.00% (115/115) and ectopic pancreas for 86.67% (13/15). ⑥ The total coincidence rate of endoscopic type diagnosis and postoperative pathological diagnosis of duodenum SMT was 58.33% (7/12), including cyst for 66.67% (4/6) and lipoma for 75.00% (3/4). ⑦ The total coincidence rate of endoscopic and postoperative pathological diagnosis of esophageal and gastric SMT were significantly higher than duodenum(P<0.05). Conclusion: Most of SMT in esophagus and cardia belong to leiomyoma, most of SMT in fundus and body of stomach are leiomyoma and stromal tumor, and the main pathological types of SMT in antrum and duodenum are heterotopic pancreas, cyst and lipoma. Then different types of SMT in different parts have special endoscopic characteristics. |
[1] NABI Z,RAMCHANDANI M,SAYYED M,et al.Outcomes of submucosal tunneling endoscopic resection in upper gastrointestinal sub-epithelial tumors[J].Indian J Gastroenterol,2020,30(1):105-112.
[2] ARAJO-MARTINS M,PIMENTEL-NUNES P,LIBÂNIO D,et al.How is endoscopic submucosal dissection for gastrointestinal lesions being implemented? Results from an international survey[J].GE Port J Gastroenterol,2020,27(1):1-17.
[3] YANG D,KOTZEV A I,DRAGANOV P V.Endoscopic submucosal dissection for early gastric cancer in the West:the absolute but not final word[J].Gastrointest Endosc,2019,90(3):480-482.
[4] WANG Z,ZHENG Z,WANG T,et al.Submucosal tunneling endoscopic resection of large submucosal tumors originating from the muscularis propria layer in the esophagus and gastric cardia[J]. Gastroenterol,2019,57(8):952-959.
[5] JAIN D,DESAI A,MAHMOOD E,et al.Submucosal tunneling endoscopic resection of upper gastrointestinal tract tumors arising from muscularis propria[J].Ann Gastroenterol,2017,30(3):262-272.
[6] KIM S J,CHOI C W.Common locations of gastric cancer:review of research from the endoscopic submucosal dissection era[J].J Korean Med Sci,2019,34(35):e231.
[7] KUMARASINGHE M P,BOURKE M J,BROWN I,et al.Pathological assessment of endoscopic resections of the gastrointestinal tract:a comprehensive clinicopathologic review[J].Mod Pathol,2020,6(1):84-89.
[8] GAJZER D C,FLETCHER C D,AGAIMY A,et al.Primary gastrointestinal liposarcoma-a clinicopathologic study of 8 cases of a rare entity[J].Hum Pathol,2019,26(12):815-822.
[9] HE M F,JIANG Z W,HAO Z W,et al.Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer:a meta-analysis[J].Zhonghua Wei Chang Wai Ke Za Zhi,2019,22(12):1196-1204.
[10] MILOSAVLJEVIC T,POPOVIC D,ZEC S,et al.Accuracy and pitfalls in the assessment of early gastrointestinal lesions[J].Dig Dis,2019,37(5):364-373.
[11] CHA J H,JANG J S.Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection[J].Turk J Gastroenterol,2020,31(1):36-41.
[12] ENDO K,AOYAMA T,MAEZAWA Y,et al.A case of a resected giant gastric schwannoma by laparoscopic surgery[J].Gan To Kagaku Ryoho,2019,46(10):1662-1664.
[13] KIM J M,SOHN J H,CHO M Y,et al.Inter-observer reproducibility in the pathologic diagnosis of gastric intraepithelial neoplasia and early carcinoma in endoscopic submucosal dissection specimens:a multi-center study[J].Cancer Res Treat,2019,51(4):1568-1577.
[14] BOUCHARD P,MOLINA J C,COOLS-LARTIGUE J,et al.Endoscopic submucosal dissection for esophageal adenocarcinoma:a north American perspective[J].J Gastrointest Surg,2019,23(6):1087-1094.
[15] NOH C K,JUNG M W,SHIN S J,et al.Analysis of endoscopic features for histologic discrepancies between biopsy and endoscopic submucosal dissection in gastric neoplasms:10-year results[J].Dig Liver Dis,2019,51(1):79-85.
[16] RYU D G,CHOI C W,KANG D H,et al.Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia[J].Medicine (Baltimore),2018,97(33):e11802. |